Session Recap: Viewing Unusual Volume for Ascendis Pharma A/S (NASDAQ:ASND)

Wedbush reissued an outperform rating and issued a $10.71 target price (down previously from $65.00) on shares of Ascendis Pharma A/S in a report on Friday. EcoR1 Capital LLC now owns 1,482,600 shares of the biotechnology company's stock valued at $41,157,000 after purchasing an additional 456,900 shares in the last quarter. After the recent moves, investors may also look to see if the stock has entered oversold or overbought territory and could be ripe for a bounce. About 2.72M shares traded or 2126.90% up from the average.

XAutoplay: On | OffIn after-hours trading on the stock market today, Versartis dove 84% after closing down 1.1% at 21.60. The business's quarterly revenue was down 61.4% compared to the same quarter previous year. The Massachusetts-based Monarch Partners Asset Management Llc has invested 0.31% in the stock.

A number of research firms have recently issued reports on ASND.

Ascendis Pharma A/S (NASDAQ:ASND)'s market cap, the total dollar value of all of their outstanding shares, is 1100.82m.

Current levels places Ascendis Pharma A/S (NASDAQ:ASND)'s stock about 14.86% from the 50-day high and 30.19% away from the 50-day low.

Among 5 analysts covering Ascendis Pharma (NASDAQ:ASND), 4 have Buy rating, 0 Sell and 1 Hold. Wedbush maintained it with "Outperform" rating and $34 target in Friday, March 24 report. Finally, ValuEngine raised shares of Ascendis Pharma A/S from a "sell" rating to a "hold" rating in a research note on Saturday, May 27th. The stock has "Buy" rating by Wedbush on Monday, September 11. Ascendis Pharma A/S now has an average rating of "Hold" and an average target price of $30.00. Wedbush maintained Ascendis Pharma A S (NASDAQ:ASND) rating on Friday, September 22.

About 44,382 shares traded. Wells Fargo & Company restated a "buy" rating and issued a $51.00 price target on shares of Ascendis Pharma A/S in a research report on Friday. The biotechnology company reported ($1.04) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.80) by ($0.24). Analysts forecast earnings per share of $-0.84, down exactly $0.04 or 5.00 % from 2014's $-0.8 EPS.

Looking ahead, Ascendis' phase 3 heiGHt trial for TC-hGH treatment of pediatric growth hormone deficiency is on track to finish enrollment in the fourth quarter of this year.

According to, which ranks over 7,500 financial analysts and bloggers to gauge the performance of their past recommendations, Jim Birchenough and Liana Moussatos have a yearly average return of 26.9% and 8.6% respectively. Ascendis Pharma A S (NASDAQ:ASND) has risen 96.01% since September 23, 2016 and is uptrending.

TRADEMARK VIOLATION NOTICE: This news story was originally published by Equities Focus and is the property of of Equities Focus.

Traders are a little more bearish on Ascendis Pharma A/S - American if you take note of the increase in short interest. The Company is involved in applying its TransCon technology to develop sustained release prodrug therapies with several product candidates in clinical and preclinical development.

Like this


24 September 2017
Ryan Giggs' reaction to Gareth Barry breaking his Premier League appearance record
He added: "What happened to Kieran Gibbs is he had been bothered [by injury] a few times when he was in front of our players". He had some fitness worries and that stopped him here.

24 September 2017
Ander Herrera labels Manchester City as title favourites due to summer spending
The Blues' last league outing saw David Luiz become the fourth man sent off for them this season, including the Community Shield. We won three titles last season and City didn't win anything. "But I don't see them as a team with a discipline problem".

24 September 2017
SC escapes Louisiana Tech with late field goal
Redshirt freshman Parker White connected on a 31-yard field goal with five seconds left to lift the Gamecocks. Louisiana Tech: The Bulldogs host South Alabama on Saturday in their final non-conference game of the year.

24 September 2017
5 things to watch in Giants-Eagles game
Therefore, expect them to bounce back against Philadelphia's defensive backs. "Yeah, we're getting them both ready to go". Last week , the Giants celebrated the 10th anniversary of the franchise's victory against New England in Super Bowl XLII.

24 September 2017
Ander Herrera Playing Mind Games With Manchester City Already
Andy Townsend believes that Manchester United will be one of the main contenders for the Premier League title this season. City will be expected to add to their win total on Saturday when they host last-placed Crystal Palace.

24 September 2017
Conte explains why Chelsea farmed Zouma out on loan
Chelsea will be looking to get a win under their belt after their disappointing 0-0 draw with Arsenal last weekend. This return to action bodes well for when Chelsea face Stoke in a tough away encounter at the bet365 Stadium .

24 September 2017
Guggenheim Capital LLC Acquires 14427 Shares of Ameriprise Financial Services, Inc. (AMP)
Finally, Airain ltd purchased a new stake in shares of Ameriprise Financial Services during the 2nd quarter valued at $1,184,000. Following the completion of the transaction, the vice president now owns 10,956 shares in the company, valued at $1,590,263.40.

24 September 2017
Several people sprayed with 'noxious substance' at London shopping center
Six people have been injured and a man has been arrested after an alleged noxious substance attack in east London. Witnesses say the situation at the Stratford Shopping Centre started with an argument between a group of people.

24 September 2017
China imposes limit on oil supply to North Korea
China's Earthquake Administration said the quake was not a nuclear explosion and had the characteristics of a natural tremor. We can not conclusively confirm at this time the nature (natural or human-made) of the event.

24 September 2017
Clock ticks down on Mexico quake rescue
Soldiers, rescuers and medics worked relentlessly, including some who said they had been there for 36 hours before being relieved. He said the only evidence of a possible survivor were images from a camera lowered into the rubble that showed the blood traces.